First human tests for new Anti-Clotting drug
NCT ID NCT07133191
Summary
This early-stage study tested a single dose of an experimental drug called selatogrel in healthy volunteers. The main goal was to understand how the drug is absorbed and broken down by the body and to check its safety. The study involved 32 healthy participants, split evenly between Japanese and Caucasian volunteers, to see if there were any differences in how their bodies handled the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CenExel ACT (Anaheim Clinical Trials)
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.